112.95USD-0.71%Mkt Cap: 12.60B $P/E: 54.301d ago
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and servi…
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/E
Pricier
P/B
Cheaper
Div Yield
Higher
1M Perf
Avg
$192.35BUSDP/E 28.4
$137.04BUSDP/E 37.5
$45.79BUSDP/E 44.2
$44.57BUSDP/E 41.5
$40.64BUSD
$37.20BUSDP/E 48.3
$36.91BUSDP/E 26.2
$34.38BUSDP/E 25.6
$29.40BUSDP/E 35.4
$26.44BUSDP/E 30.8
$23.63BUSDP/E 23.6
$23.32BUSDP/E 25.2
$22.39BUSD
$16.14BUSDP/E 35.6
$12.97BUSDP/E 27.0
$11.15BUSD
$9.03BUSDP/E 21.1
$6.22BUSD
$5.68BUSDP/E 228.5
$5.42BUSD
$5.09BUSDP/E 43.6
$4.63BUSDP/E 53.7
$3.60BUSDP/E 25.5
$3.39BUSD
$2.96BUSD
$2.05BUSD
$1.97BUSD
$1.52BUSDP/E 38.7
$1.55BUSDP/E 23.3
$1.50BUSD
$1.50BUSD
$1.13BUSD
$1.01BUSDP/E 21.1
$734.29MUSD
$623.59MUSDP/E 40.6
$607.49MUSD
$569.52MUSD
$297.91MUSDP/E 3.0
$290.61MUSD
$226.27MUSD
$182.12MUSD
$141.76MUSD
$106.30MUSD
$97.25MUSD
$94.30MUSDP/E 18.1
$79.32MUSD
$58.94MUSD
$45.15MUSD
$29.61MUSD
$27.97MUSD
$21.38MUSD
$17.72MUSD
$12.73MUSD
$12.18MUSD
$9.97MUSDP/E 62.6
$9.04MUSD
$9.20MUSD
$6.08MUSD
$5.34MUSD
$4.90MUSD
$5.08MUSD
$5.06MUSD
$3.86MUSDP/E 2.8
$3.69MUSD
$3.29MUSD
$3.29MUSD
$2.79MUSD
$1.01MUSD
$314.2KUSDP/E Infinity
$56.1KUSD
Indicators:|
Key Statistics
Company
Market Cap12.60B $
Enterprise Value14.90B $
Revenue (TTM)2.90B $
Gross Profit1.56B $
Net Income (TTM)241.20M $
Revenue/Share25.36 USD
Last Price112.95 USD
Fiscal Year EndDec 2025
MR QuarterApr 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)54.30
P/E (Forward)19.09
PEG0.69
EV/EBITDA17.42
EV/Revenue5.13
P/S4.28
P/B1.73
EPS (TTM)2.08
EPS (Forward)5.83
52W Range
81.2286% of range118.30
52W High118.30 USD
52W Low81.22 USD
Profitability
Gross Margin54.77%
Oper. Margin12.35%
EBITDA Margin29.47%
Profit Margin8.45%
ROE3.33%
ROA1.98%
Growth
Revenue Growth7.00%
Earnings Growth3.50%
Cash Flow & Leverage
Operating CF582.93M $
CapEx (TTM)73.52M $
FCF Margin17.54%
FCF Yield4.04%
Net Debt2.49B $
Net Debt/EBITDA2.91
Balance Sheet
Debt/Equity0.47
Current Ratio1.72
Quick Ratio1.25
Book Value/Sh64.34 USD
Cash/Share7.712 USD
Dividends
Fwd Div Rate0.2800 USD
Trail. Div Rate0.2800 USD
Div. Yield0.25%
5Y Avg Yield0.24%
Payout Ratio13.46%
Ex-Div DateJul 17, 2026
Pay DateAug 7, 2026
Splits
Last Split2:1
Split DateJun 4, 2001
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)113.73 USD
Upside (mean)+0.7%
Target Range90.00 USD – 145.00 USD
$90.00+0.7% to mean$145.00
# Analysts15
Ownership
Shares Out.111.56M
Float102.14M
Insiders0.36%
Institutions105.81%
Short Interest
Short Ratio5.7d
Short % Float11.17%
Short % Out.7.46%
Shares Short8.32M
Short (prev mo.)9.52M
Technical
SMA 5097.36 (+16.0%)
SMA 20096.19 (+17.4%)
Beta1.11
S&P 52W Chg20.05%
Avg Vol (30d)1.10M
Avg Vol (10d)1.71M
Technical Indicators
RSI (14)66.1
MACD4.0904
MACD Signal3.2059
MACD Hist.+0.8845
BB Upper117.12 USD
BB Middle104.90 USD
BB Lower92.68 USD
BB Width23.31%
ATR (14)3.943 USD
Vol Ratio (20d)0.54x